Biotechnology
In This Section
- AIPPI-US
- Alternative Dispute Resolution (ADR)
- Amicus
- Antitrust Law
- Biotechnology
- Chemical Practice
- Copyright Law
- Corporate Practice
- Diversity in IP Law
- Electronic and Computer Law
- Emerging Technologies
- AIPLA Fellows
- Food and Drug
- Harmonization
- Industrial Designs
- International and Foreign Law
- International Trade Commission
- IP Law Associations
- IP Practice in China
- IP Practice in Europe
- IP Practice in Israel
- IP Practice in Japan
- IP Practice in Latin America
- IP Practice in the Far East
- IP Transactions
- Law Practice Management
- Legislation
- Membership
- Mentoring
- Mergers and Acquisitions
- New Lawyers
- Online IP Enforcement & Anti-Counterfeiting Committee
- Online Programs
- Patent Agents
- Patent Cooperation Treaty Issues
- Patent Law
- Patent Litigation
- Patent Relations With the USPTO
- Privacy & Data Security
- Pro Bono
- Committee on the Profession
- Professional Programs
- PTAB Trial
- Public Appointments
- Standards and Open Source
- Trade Secret Law
- Trademark Law
- Trademark Litigation
- Trademark Treaties and International Law
- Trademark-Relations with the USPTO
- Women in IP Law
To realize the promise of Biotechnology in health, energy, environment, and food requires a reliable, global IP system that rewards innovation without inhibiting it and protects investments in new products and new jobs. Biotechnology IP practitioners and companies, however, face very significant challenges in helping the world realize this promise.
The overall mission of the Biotechnology Committee is to serve as resource, educator, and advocate for its members, AIPLA, government institutions, and people everywhere so that the promise of Biotechnology may be more fully realized globally.
Key Initiatives
- The Committee strives to be an active resource and open forum for biotechnology patent practitioners. Topics of interest (controversial or otherwise) are covered in various forums such as the committee's website and CLE programs at the stated meetings.
- The Committee also serves as a resource for AIPLA when positions relevant to biotechnology are taken. Recent examples of such assistance include commenting on the USPTO’s proposed rule changes regarding Markush claim practice and biological deposit practice, and assisting in directing AIPLA for positions on proposed legislation, such as the Becerra bill, which sought to prohibit the patenting of genetic material.
How You Can Participate
Participation is open to all AIPLA members. Join the committee and actively engage in the online community.Become an AIPLA member and login in and join the Biotechnology committee in your profile. Once you join, please visit the Online Community and begin engaging with your peers.